Ultrapar Participacoes S A : PARTICIPAÇÕES S.A. MARKET ANNOUNCEMENT - Form 6-K

ULTRAPAR PARTICIPAÇÕES S.A. MARKET ANNOUNCEMENT Update on the exercise of Extrafarma's Preemptive Right

SãoPaulo,July 25,2022-UltraparParticipações S.A. (B3: UGPA3; NYSE: UGP, "Ultrapar"or "Company"), in addition to the material notice of May 18, 2021, the notice to shareholders of June 28, 2021 ("Notice to Shareholders") and the market announcement of June 22, 2022, hereby informs that, in the context of the sale of Extrafarma to PagueMenos ("Transaction"), the calculations of the preliminary adjustment of Extrafarma's Acquisition Price have been completed, pursuantto the method of calculationset forthin the documents of the Transaction, summarized in Exhibit I of the Notice to Shareholders, resulting in an acquisition price of Extrafarma's shares of R$ 0.549643per share ("Preliminary Acquisition Adjusted Price").

Considering that the Preliminary Acquisition Adjusted Price is higher than the Acquisition Price, namely, R$ 0.447091 per share, and that all shareholders who exercised the Preemptive Right chose to pay the Acquisition Price in advance, in cash, such shareholders shallpay the difference between the Acquisition Price and the Preliminary Acquisition Adjusted Price, namely R$ 0.102552per share, within 5days from the date hereof, that is, July 30, 2022. Failure to make such payment within the above mentioned time frame shall imply the forfeiture of the Preemptive Right. Such amount shall be paid to Ultrapar, in Brazilian currency, by means of an electronic transfer (TED) of immediately available funds or PIX (instant payment system from Central Bank of Brazil) to the bank account 22500-2, branch 2374, at Banco Bradesco, owned by IpirangaProdutos de Petróleo S.A. (CNPJ and PIX key 33.337.122/0001-27). To allow the verificationofperformance of the above mentioned obligation, shareholders are requested to forward proof of payment, preferably until July 30, 2022, to the Company's electronic address [e-mail], indicating the shareholder(s) to whom the transferred proceeds refer.

The Preliminary Acquisition Adjusted Price isstill subject to the Acquisition Price Final Adjustment, as detailed in the Notice to Shareholders. The procedures to be adopted by the shareholders exercising the Preemptive Right upon the indication of the Acquisition Price Final Adjustment will be disclosed by the Company in due course.

Finally, Ultrapar clarifies that the effective transfer of Extrafarma's shares as a resultof the exercise of the Preemptive Right will be carried out after the determination of the Final Acquisition Price and, as the case may be, the payment by the shareholders exercising the Preemptive Right of the eventual difference between the Final Acquisition Price and the Preliminary Acquisition Adjusted Price, as per item 2.4 of the Notice to Shareholders.

Ultrapar will maintainthe market and its shareholders duly informed of any relevantupdates related to this announcement.

Rodrigo de Almeida Pizzinatto

Chief Financial and Investor Relations Officer

Ultrapar Participações S.A.

Capitalized terms not expressly defined in this document shall have the meaning assigned to them in the Notice to Shareholders.